Cargando…

Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study

Objective To evaluate safety alerts and recalls, publication of key trial outcomes, and subsequent US approval of high profile medical devices introduced in the European Union. Design Cohort study. Setting Novel cardiovascular, orthopedic, and neurologic devices approved in the EU through Conformité...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Thomas J, Sokolov, Elisaveta, Franklin, Jessica M, Kesselheim, Aaron S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925918/ https://www.ncbi.nlm.nih.gov/pubmed/27352914 http://dx.doi.org/10.1136/bmj.i3323

Ejemplares similares

Clinical Benefit and Expedited Approval of Cancer Drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia
por: Hwang, Thomas J., et al.
Publicado: (2022)

How Does Medical Device Regulation Perform in the United States and the European Union? A Systematic Review
por: Kramer, Daniel B., et al.
Publicado: (2012)

Approval and Certification of Ophthalmic AI Devices in the European Union
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
por: Yano, Kazuo, et al.
Publicado: (2014)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review
por: Wang, Bo, et al.
Publicado: (2015)

Compassionate use of drugs and medical devices in the United States, the European Union and Japan
por: Tsuyuki, Kenichiro, et al.
Publicado: (2016)

Landscape of Cardiovascular Device Registries in the United States
por: Rajan, Prashant V., et al.
Publicado: (2019)

Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015)

Post‐Marketing Requirements for Cancer Drugs Approved by the European Medicines Agency, 2004–2014
por: Cherla, Avi, et al.
Publicado: (2022)

Radiation Oncology Device Approval in the United States and Canada
por: Beers, Craig A, et al.
Publicado: (2019)

A survey on the state of nanosafety research in the European Union and the United States
por: Duschl, Albert, et al.
Publicado: (2018)

Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys
por: Feldman, William B., et al.
Publicado: (2019)

Cell-based medicinal products approved in the European Union: current evidence and perspectives
por: Bellino, Stefania, et al.
Publicado: (2023)

Report on the state of the European Union /
Publicado: (2005)

Regulation of medical devices outside the European Union
por: Lamph, Susan
Publicado: (2012)

How are medical devices regulated in the European Union?
por: French-Mowat, Elaine, et al.
Publicado: (2012)

Navigating the maze of requirements for obtaining approval of non-interventional studies (NIS) in the European Union
por: Ramirez, Isabelle
Publicado: (2015)

Engineered Microorganisms for the Production of Food Additives Approved by the European Union—A Systematic Analysis
por: Kallscheuer, Nicolai
Publicado: (2018)

Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016
por: Morant, Anne Vinther, et al.
Publicado: (2019)

The legal frameworks that govern fetal surgery in the United Kingdom, European Union, and the United States
por: Cao, Kevin X., et al.
Publicado: (2018)

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
por: Magnani, Giulia, et al.
Publicado: (2015)

Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States
Publicado: (2015)

Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
por: Mostaghim, Sana R, et al.
Publicado: (2017)

Patient-reported outcome claims in European and United States orphan drug approvals
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Drugs and Devices: Comparison of European and U.S. Approval Processes
por: Van Norman, Gail A.
Publicado: (2016)

Getting the Right Evidence After Drug Approval
por: Vreman, Rick A., et al.
Publicado: (2020)

Medicare Spending on Drugs With Accelerated Approval, 2015-2019
por: Rome, Benjamin N., et al.
Publicado: (2021)

Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

The strength of a weak centre: pandemic politics in the European Union and the United States
por: Alexander-Shaw, Kate, et al.
Publicado: (2023)

Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
por: Feldman, Daniel, et al.
Publicado: (2022)

States and regions in the European Union : institutional adaptation in Germany and Spain /
por: Börzel, Tanja A.
Publicado: (2002)

Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
por: Hwang, Thomas J, et al.
Publicado: (2020)

An evaluation of drug lag for new drugs approved by the Indian regulator relative to the United States, European Union, and Japanese regulatory agencies: A 15-year analysis (2004–2018)
por: Konwar, Mahanjit, et al.
Publicado: (2021)

Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval
por: Kesselheim, Aaron S., et al.
Publicado: (2016)

COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients
por: Bellino, Stefania
Publicado: (2022)

The risk of Rift Valley fever virus introduction and establishment in the United States and European Union
por: Rolin, Alicia I, et al.
Publicado: (2013)

Delay and restricted access of new molecules in Turkey compared to the United States and European Union
por: Şahin, Toros, et al.
Publicado: (2013)

Austerity and Abortion in the European Union
por: Lima, Joana Madureira, et al.
Publicado: (2016)

Insights into the primate trade into the European Union and the United Kingdom
por: Svensson, Magdalena S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5j2g3gm2ha6ju0b5hapt5kqkp0